Objective: Germinal center resident follicular helper T (TFH) cells in lymphoid follicles are a potential sanctuary for HIV/simian immunodeficiency virus (SIV) replication. But the dynamics of germinal centers upon early initiation of antiretroviral therapy (ART) and their potential role in the formation of viral sanctuaries post-SIV infection are not fully understood.
Introduction
With the advent of an increasing array of antiretroviral drugs, the outcome of clinical HIV infection has drastically improved, whereby HIV replication can be controlled to undetectable levels, virtually eliminating the development of classical AIDS [1] . However, even improved antiretroviral therapy (ART) has so far failed to clear the infection, requiring lifelong treatment, because of the presence of long-lived cellular viral reservoirs and anatomical sanctuaries even after prolonged potent viral suppression [2] .
One such reservoir within lymphoid tissues are germinal center follicular helper T (TFH) cells potentially because of the physiological exclusion of CD8 þ T-cell effectors from the germinal center [3] [4] [5] . In the context of chronic HIV/simian immunodeficiency virus (SIV) infection, a marked expansion of TFH cells has been observed in lymph nodes of patients or monkeys, compared with levels recorded at baseline or from uninfected individuals [4, 6, 7] . Although prolonged ART has been shown to decrease the relative frequency of germinal center TFH cells in lymph nodes, their representation still remains significantly elevated relative to healthy individuals [6, 7] . However, the dynamic of germinal center TFH cells during early ART initiation has not been well documented, which has implications in the seeding and maintenance of viral reservoirs [8] . In efforts to evaluate whether inhibition of SIV replication would inhibit lymphoid hyperplasia, we investigated the dynamics of lymphoid activation longitudinally during early chronic infection, with ART initiated before the appearance of full-blown follicular hyperplasia post-SIV infection [9] .
Materials and methods
All animals used in this study were born and maintained at the Yerkes National Primate Research Center of Emory University in accordance with the regulations of the Guide on the Care and Use of Laboratory Animal Resources. All experiments were approved by the Emory Institutional Animal Care and Use and Biosafety Committees. The animals were inoculated with 200 TCID 50 (50% tissue culture infectious doses) of SIVmac239 intravenously and served as a source for blood and lymph node biopsies at various time points postinfection.
Antiretroviral therapy treatment
ART comprised a three-drug regimen, including: 9-R-(2-phosphonomethoxypropyl) adenine (PMPA, 20 mg/kg/day) and emtricitabine (FTC, 30 mg/kg/day) both from Gilead (Foster City, California, USA) and administered subcutaneously and an integrase inhibitor (raltegravir, 100 mg/day orally, courtesy of Merck, West Point, Pennsylvania, USA) initiated at 5 weeks post-SIV infection for 3 months.
Quantitation of SIV RNA/DNA in plasma and lymph nodes Plasma SIV RNA load and cellular SIV DNA/RNA were determined by quantitative RT-PCR and PCR as described previously [10] .
Flow cytometry
Peripheral lymph nodes were collected at baseline before SIV infection, and at 5, 11, and 17 weeks postinfection (wpi) and processed for in-situ analyses as well as for isolating mononuclear cells as previously described [11, 12] . One million freshly isolated mononuclear cells were stained for live/dead marker (Alexa 430, A10169; Invitrogen, Carlsbad, California, USA) and then stained with predetermined concentrations of antibodies against CD3 (SP34-2), CD4 þ (L200), CD8 þ (RPA-T8), CD20 (L27), CD28 (CD28.2), CD95 (DX2) and PD1 (EH12.2H7). Cells were incubated with the antibody cocktail for 30 min at 48C, washed with phosphatebuffered saline (PBS) containing 2% Fetal Bovine Serum (FBS, Atlanta Biologicals, Atlanta, Georgia, USA), cells were then fixed in 1% paraformaldehyde, and the data acquired on LSR-II flow cytometer driven by FACS DiVa software. Analysis of the acquired data was performed using FlowJo software, version 9.2 (TreeStar, Ashland, Oregon, USA).
Immunofluorescent staining and quantitative image analysis
Staining procedures were performed as described previously [9, 13] . Lymph node sections were cut (4 to 5 mm) and incubated with mouse antihuman Ki67 (Vector Labs, Burlingame, California, USA), rabbit antihuman CD20 (Thermo Scientific, Waltham, Massachusetts, USA), and goat antihuman PD1 (R&D Systems, Minneapolis, Minnesota, USA) antibodies after heat-induced epitope retrieval. Sections were also stained for SIVgag p17 using mouse anti-p27 (KK59, NIH AIDS Repository Reagent Program). Thereafter, the sections were counter stained with Hoechst 33342 (Invitrogen). Every step was followed by three washes with Trisbuffered saline automation buffer (Biocare, Pacheco, California, USA). All images were acquired with an Axio Imager Z1 microscope (Zeiss, Mumbai, India) using various objectives. The germinal center size was calculated based on both nucleus dye and Ki67 staining of germinal center B cells in AxioVs40 V4.8.1.0 program (Zeiss), as described previously [9] . The hematoxylin and eosin-stained lymph node sections were blindly evaluated by a veterinary pathologist.
Elisa immunosorbent spot
Standard Elisa immunosorbent spot assays were performed as described previously [14] . In total, 96 well plates (EMD Millipore, Billerica, Massachusetts, USA) were coated with 10 mg/ml of anti-monkey immunoglobulin (Ig)G, IgA, and IgM (H and L) goat antibody (Rockland Immunochemicals, Pottstown, Pennsylvania, USA) or 2 mg/ml of recombinant SIV envelope (Env) overnight at 48C for enumeration of antibody secreting cells (ASCs). Wells were blocked with complete RPMI medium for 2 h at 378C. Whole lymph node cell preparations were diluted, plated in serial three-fold dilutions and incubated overnight at 378C. Wells were then incubated for 2 h at room temperature (RT) with biotin-conjugated antimonkey IgG (Rockland), diluted 1 : 1000 in PBS with 0.05% tween 20 and 1% FBS. Wells were incubated for 3 h at RT with Avidin D-HRP (Vector Labs), diluted 1 : 1000. Spots were developed with filtered 3-amino-9-ethylcarbazole substrate and then counted using the immunospot CTL counter and the Image Acquisition v4.5 software (Cellular Technology, Shaker Heights, Ohio, USA).
Results
In total, 10 rhesus macaques were injected with SIVmas239 intravenously, allowed to undergo acute infection and initiated on daily ART at 5 wpi for 3 months. Plasma SIV RNA (vRNA) levels reached their peak replication at about 2 wpi and early viral load set points by 5 wpi (10 4 -10 6 vRNA copies/ml). By 7 wpi (2 weeks after ART initiation), nine out of 10 monkeys had plasma viral loads below the detection limit of the assay (50 copies/ml), whereas the last animal reached that level at 8 wpi (Fig. 1d) . In lymph nodes, quantification of SIV RNA and DNA showed a significant decrease in the level of both replicating virus RNA and proviral DNA in lymph node cells collected from 5 to 11 wpi and a second order decrease from 11 and 17 wpi under ART (Fig. 1e) .
Germinal center TFH cells were defined by high-density PD-1 expression of gated central memory CD4
þ T cells as previously described (Fig. 1a) . The frequency of germinal center TFH cells was monitored at baseline, 5, 11, and 17 wpi (Fig. 1b) . Although the kinetics of early expansion of TFH showed considerable individual differences as previously reported [9] , by 5 wpi, a significant, albeit modest, overall increase in TFH frequencies was noted (8.3 AE 1.4%, P ¼ 0.0095). We had previously demonstrated a marked TFH expansion by 4 months postinfection in the absence of ART [9] . Surprisingly, in spite of the profound control of viral replication induced by ART to almost undetectable levels, a marked expansion of TFH cells was noted in all animals on ART from 5 to 11 wpi (19.7 AE 2.7% at 11 wpi) (Fig. 1c) . These increased levels were maintained at 17 wpi (16.31 AE 3.3%), suggesting that lymphoid activation was not directly linked to levels of viral replication in vivo. At that stage of infection, TFH expansion in ART-treated monkeys was lower than in monkeys infected with the same stock and route of SIVmac239 without ART treatment (16.31 AE 3.3% at 17 wpi for ART treated vs 48.2 AE 5.3% at 16$19 wpi for untreated monkeys) [9] . The functional consequence of TFH and germinal center expansion was tested by enumerating the number of total IgG and SIV Env (gp140)-specific IgG secreting cells (ASC) pre and during ART. Relatively high frequencies of SIV Env-specific ASCs were detected at 5 wpi in lymph nodes that markedly decreased after 6 weeks of ART (Supplemental Figure 1b , http:// links.lww.com/QAD/B124, 1131.9 AE 188.7% at 4 wpi, and 225.8 AE 57.7% at 11 wpi, P ¼ 0.0008), suggesting that differentiation of antigen specific and overall B cells into ASCs is indeed linked to the magnitude of virus replication.
Increases in TFH cells are generally associated with histological changes of the lymphoid architecture, in particular, a more delineated definition of the follicles and formation of germinal centers. We next investigated the sequential development of germinal centers in lymph nodes from the same rhesus macaques using in-situ methods as previously described [4, 9] . Consistent with the increased frequencies of TFH cells measured by flow cytometry (Fig. 1) , the relative germinal center size was significantly increased at 5 wpi compared to baseline (9.7 AE 2.9% at 0 wpi vs 22.9 AE 4.0% at 4 wpi, P ¼ 0.0095; Fig. 2 ). The increase in activated B cells was confirmed by flow cytometry in this compartment and these cells were shown to be present primarily in the germinal center (Supplemental Figure 2 , http://links.lww.com/QAD/ B124). However, this expansion was not uniform across all animals with a direct correlation with relative germinal center size and TFH frequencies (data not shown). At 11 wpi, the relative germinal center size had increased to 54.3 AE 5.0%, with a nonsignificant decrease to 39.6 AE 4.3% by 17 wpi (12 weeks on ART). Similar to observations made during chronic untreated SIV infection [4, 9] , the accumulation of proliferating B cells was restricted to germinal centers of hyperplastic follicles, associated and potentially resulting from the high expression of IL-21 ( Fig. 2a and b) . By contrast, few SIV Gag P17-stained cells were detected in hyperplastic follicles after 3 months of ART (Fig. 2b) . Of interest, the relative size of germinal centers within B cell follicles 1822 AIDS 2017, Vol 31 No 13 developed to a rate similar to the one observed in hyperplastic follicles from lymph nodes of typical untreated SIV progressors by 16$19 wpi (54.4 AE 3.5% at 16$19wpi) [9] , suggesting that the development of follicular hyperplasia is associated with local production of IL-21 rather than levels of virus present within germinal centers.
Discussion
TFH cells are central to the formation and development of germinal centers and elicitation of a durable humoral response in lymphoid tissues [15] upon antigen-specific stimulation, via either immunization or in response to infection [16, 15] . During the course of HIV/SIV infections, lymphadenopathy is a hallmark of inflammation, including an accumulation of a heterogeneous array of germinal center TFH cell subsets in lymphoid follicles [4, [17] [18] [19] . As germinal center TFH cells are also targets of HIV/SIV infection [18, 20, 21] , the extensive expansion of this compartment and its maintenance during infection needs to be taken into consideration when addressing viral reservoirs during ART.
In the SIV-infected macaque model, significant changes in the lymphoid architecture and expansion of TFH in lymph nodes occur at the early chronic infection stage compared with uninfected and acutely infected rhesus macaques [4, 9] . It was hypothesized that early elimination of viremia prior to fully developed lymphoid hyperplasia would result in a return to baseline values for germinal center size and TFH frequencies, given the potent control of viral replication by ART in vivo. Quite surprisingly, our results show unequivocally that the follicular hyperplasia initiated by the acute infection developed at about the same rate and almost to the same magnitude as the ones observed in SIV infected but untreated monkeys [9] . This maintenance of expansion was not fueled by SIV antigen as demonstrated by decreased viral loads in the local tissue as well as ASCs under ART (Supplemental fig 1b, http:// links.lww.com/QAD/B124) [22, 23] , but appears to be associated with elevated levels of cytokines such as IL-21, that resulted from the initial acute infection [24] . This protracted activation of lymphoid tissues long beyond elimination of active viral replication in vivo suggests that the resolution of this immune-activated state likely will require extensive time on ART to decrease back to 'normal levels', if ever. The maintenance of germinal center TFH cells has traditionally thought to be a result of several factors, including a relatively lower concentration of anti-HIV drugs within the lymphoid compartment relative to blood, allowing for the continued low-level replication in these tissues (a.k.a. smoldering infection) [25] , a germinal center niche with follicular dendritic cells which may contain viral proteins such as p24 antigen that persist longer without virus replication under ART [26, 27] , low levels of replicating virus from activated germinal center TFH cells, which might suffice to recruit new cells to germinal centers and maintain the cycle [5] , and residual HIV-immune reconstitution inflammatory syndrome, encompassing proinflammatory IL-6, TNF-a, and others, that may play a paramount role in maintaining TFH cells and germinal center responses in rhesus macaques receiving ART [28] . Although there is data in support of each mechanism cited, an important observation has been the fact that germinal center TFH cells were recently shown to represent a critical reservoir and even maintain persistent productive virus infection, compared with non-TFH cells in SIV-infected elite controller macaques [5] and human patients on ART [29] . Our present data suggest that follicular hyperplasia is ongoing irrespective of the continued presence of viral antigen, and this hyperplasia provides a viral reservoir from which virus has been shown to rebound upon ART cessation [30, 31] . Thus, an intact germinal center environment with accumulation of TFH cells in hyperplastic follicles acts as the crucial niche from which virus replication can rapidly rekindle upon ART interruption. Although our data do not definitely identify the mechanism at play during ART, we submit that the demonstration of continued lymphoid hyperplasia in the absence of extensive viral replication may represent another issue that should be considered therapeutically. For these reasons, we suggest that manipulation of germinal center architecture in lymphoid follicles might provide a testable therapeutic approach to attempt to control virus rebound after ART cessation. Of note, transplantation studies are underway to test which combination of immunosuppressive drugs attenuates germinal center-related donor-specific antibody production in experimental transplantation [13, 32, 33] . Indeed, blockade of CD28-mediated signals significantly altered germinal center formation in a monkey renal transplant model [13] , which could represent yet another avenue to contain the viral reservoir in its latent state.
